Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 2 |  Yuan Eric S.Director, Chief Executive Officer |  ZMZoom Communications, Inc.Grant or award | A | — 561.6K sh |
| Apr 13, 2026 traded Apr 9, 2026 |
| 1 | Rosenbaum Michael GeorgeDirector, Chief Executive Officer |  GWREGuidewire Software, Inc.Open-market sale · 10b5-1 plan | SELL | $143K 1,200 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 1 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. |  ANIPANI PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $39K 500 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Pomel OlivierDirector, Chief Executive Officer |  DDOGDatadog, Inc.Option exercise · 10b5-1 plan | M | $35K 38.1K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Pomel OlivierDirector, Chief Executive Officer | DDOGDatadog, Inc. Derivative conversion · 10b5-1 plan | C | — 42.4K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 8,109 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer |  MLYSMineralys Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $35K 2,170 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Pelish Henry E.Chief Scientific Officer |  NUVLNuvalent, Inc.Option exercise · 10b5-1 plan | M | $86K 3,093 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $56K 6,613 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | MLYSMineralys Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 2,170 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $59K 8,109 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 6,613 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Howard Justyn RussellDirector, Executive Chair, 10% Owner |  SPTSprout Social, Inc.Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 0 | Chang MichelleChief Financial Officer | ZMZoom Communications, Inc. Option exercise · 10b5-1 plan | M | — 0 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Nagendran SukumarDirector, President and Head of R&D |  TSHATaysha Gene Therapies, Inc.Option exercise · 10b5-1 plan | M | $33K 19.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Perducat CyrilSVP, Chief Technology Officer | ROKROCKWELL AUTOMATION, INC Option exercise · 10b5-1 plan | M | — 581 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Pomel OlivierDirector, Chief Executive Officer | DDOGDatadog, Inc. Option exercise · 10b5-1 plan | M | — 35.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Nagendran SukumarDirector, President and Head of R&D | TSHATaysha Gene Therapies, Inc. Option exercise · 10b5-1 plan | M | — 19.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 0 | Tan Anthony Ping YeowDirector, Chief Executive Officer |  GRABGrab Holdings LtdDerivative conversion · 10b5-1 plan | C | — 800.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 56 | George GregoryDirector, 10% Owner |  MESOMESOBLAST LTDOpen-market purchase | BUY | $5.68M 4.00M sh | Apr 10, 2026 traded Apr 4, 2026 |
| 51 | Velaga S. RamPresident, ISG |  AVGOBroadcom Inc.Open-market sale | SELL | $6.08M 17.3K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 51 | Page JustineDirector | AVGOBroadcom Inc. Open-market sale | SELL | $712K 2,018 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 50 | Kawwas Charlie BPresident, SSG | AVGOBroadcom Inc. Open-market sale | SELL | $3.45M 10.0K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 47 | Velaga S. RamPresident, ISG | AVGOBroadcom Inc. Open-market sale | SELL | $4.56M 13.0K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 47 | Da Cunha Gustavo WerneckCEO and Board Member |  GGBGERDAU S.A.Open-market sale | SELL | $201K 50.0K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 45 | Collier CharlesPresident, Roku Media | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $21.61M 205.8K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 43 | Wang Chia YuanSenior management | GGBGERDAU S.A. Open-market sale | SELL | $136K 34.0K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 43 | Da Cunha Gustavo WerneckCEO and Board Member | GGBGERDAU S.A. Open-market sale | SELL | $208K 50.0K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 43 | O'Shaughnessy LauraDirector |  AYIACUITY INC. (DE)Open-market purchase | BUY | $283K 1,000 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 42 | Isaksen Bjorn Andreas FrengDirector |  HSHPHimalaya Shipping Ltd.Open-market sale | SELL | $4.02M 300.0K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 39 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $3.44M 2.32M sh | Apr 10, 2026 traded Apr 10, 2026 |
| 38 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $1.27M 886.9K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 36 | Jain SachinChief Operating Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $364K 3,953 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 36 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $3.45M 38.7K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 34 | Shetty Reshma P.Director, See remarks, 10% Owner |  DNAGinkgo Bioworks Holdings, Inc.Open-market sale | SELL | $91K 13.2K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 34 | Canton Barry10% Owner | DNAGinkgo Bioworks Holdings, Inc. Open-market sale | SELL | $91K 13.2K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 34 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $7.20M 500.0K sh | Apr 10, 2026 traded Apr 9, 2026 |